Monthly Archives: October 2012

Reasons to go for open access: perspectives from a clinician and a librarian

In recognition of Open Access week, Dr Pascal Meier an interventional cardiologist from University College London and Yale Medical School, and Whitney Townsend, the coordinator of the Health Sciences Executive Research Services at University of Michigan, provide their views on the benefits of open access publishing. Dr Pascal Meier “The only thing worse than being… Read more »

Medicine Open Access

Psychological morbidity: life after the ICU

Despite numerous clinical advances in the field of emergency medicine, patients that survive the intensive care unit (ICU) may experience prolonged psychological distress and a decreased quality of life. Although risk factors for adverse psychological outcomes such as depression, anxiety, and posttraumatic stress disorder (PTSD) have been classified, it is not known which factor poses… Read more »


Nobel prize winners a beacon for stem cell research

Congratulations from all at BioMed Central to Sir John Gurdon and Shinya Yamanaka, who share the 2012 Nobel prize in physiology or medicine for “the discovery that mature cells can be reprogrammed to become pluripotent.” Once again, stem cells are a hot topic of conversation! In 1962 John Gurdon demonstrated that adult cells retained all… Read more »


No result is worthless: the value of negative results in science

Jian Tang and Renata Curty are carrying out a study which examines the academic influence of Journal of Negative Results in BioMedicine. They are doctoral students in the Information Science and Technology Program at Syracuse University, and are interested in the Open Science movement. In this guest blog post they explore the value of publishing… Read more »

Biology Medical Evidence Medicine Open Access

Beyond the genome and onto the web


Organising a conference feels a bit like the final stages of a PhD: spending months scouring the scientific literature, a gradual increase in stress levels, followed by three manic days on a diet consisting entirely of coffee. As an organizer of the third Beyond the Genome meeting, hosted by Genome Medicine and Genome Biology and… Read more »


The September issue of Genome Medicine: Annotate-it, de novo mutations in neurological and psyquiatric diseases, epigenomics of ulcerative colitis, and more


The September issue of Genome Medicine opens with two research highlights discussing recent articles providing novel insights into the pathophysiology and treatment of chronic obstructive pulmonary disease and ulcerative colitis, inflammatory conditions with increasing incidence worldwide. On the topic of chronic obstructive pulmonary disease, Silke Meiners and Oliver Eickelberg discuss a research article published in the… Read more »